|
The Luxembourg Institute of Health (LIH) and Advanced Biological Laboratories (ABL) are joining forces to predict immune protection against COVID-19 and support long-term vaccination strategies. To this end, the two laboratories have signed a license agreement and a collaboration agreement to provide two in vitro diagnostic solutions to measure neutralizing antibody levels.
LIH has established a reference viral neutralization assay that measures the activity of neutralizing antibodies against the different SARS-CoV-2 Variants of Concerns. This assay, realized in a BSL3 laboratory, is the reference assay to provide neutralization titers and predict immune protection against COVID-19 or disease severity. To rationalize long-term COVID vaccination strategies, LIH has also...
|